Microbiome enthusiasm at Emory
Microbiome research is expanding at Emory. May this Clostidium difficile bacterium (image courtesy of CDC) not dominate your microbiome.
Hypersomnia update: clarithromycin study
“The benefit observed is large enough to be clinically meaningful,” but lots of caveats to consider. First double-blind, placebo-controlled study of a GABA-targeting drug in hypersomnia. Artwork originally from 2013 Emory Medicine story of an early hypersomnia patient.
Promising probe for detecting recurrent prostate cancer
Cancer cells’ fondness for sweets does not apply here
Redrawing the brain’s motor map
Updating Penfield, to aid in the study of dystonia
Do Alzheimer’s proteins share properties with prions?
Some “strains†of amyloid-beta may resemble spooky prions in their ability to spread within the brain, even if they can’t infect other people.
Pre-hospital recognition of severe sepsis
A tool for recognizing a potential killer when it can be stopped — tested on Grady EMS data
Why checkpoint inhibitors fall short for some types of cancer
Why immunotherapy drugs have not been effective for some type of cancer, with a focus on prostate. Cool illustration (from upcoming magazine) courtesy of Laura Coyle and Peta Westmaas
Why HIV’s cloak has a long tail
A small section of the envelope protein, located on its “tailâ€, is necessary for HIV Env to be sorted into viral particles.